BNCM Announcement: DELEX Expands ICU FORUM and Global Network of Healthcare Professionals

DELEX Pharma is proud to announce the continued expansion of its global healthcare training programs, including the highly successful DELEX ICU Forum, which has evolved from an in-person event to a dynamic online platform, now attracting nearly 200,000 healthcare professionals worldwide. This expansion reinforces DELEX’s unwavering commitment to improving healthcare outcomes and its leadership in the critical care space, while providing significant growth potential for investors.

BNCM: DELEX PHARMA Bolsters Market Reach Through 6 Major Conventions in November 2024

Delex Pharma International, Inc. (Delex Pharma) strengthened its market presence in 2024 by complementing its digital initiatives, such as the ICU Forum, with participation in six major on-ground conventions, the majority of which took place in November 2024. Additionally, we have conducted hybrid webinars and events with forty-four (44) partner medical societies and hospital departments. These events target key healthcare professionals across multiple specialties, enhancing brand visibility and engagement.

BNCM Announces that DELEX ICU FORUMS has reached a Global Audience of almost 200,000 Healthcare Professionals

September 16th, 2024; BNCM is excited to announce that the ICU (Intensive Care Unit) Forums conducted by DELEX have reached a Global Audience of almost 200,000 Healthcare Professionals.